Notice Number: NOT-AI-06-011 (Replaced by NOT-AI-07-021)
Release Date: December 19, 2005
National Institute of Allergy and Infectious Diseases (NIAID), (http://www.niaid.nih.gov)
Research aimed at developing tools to control epidemic influenza and the increasing threat of pandemic influenza is one of NIAID's highest priorities. Influenza is both a major public health threat and a NIAID Biodefense Category C priority pathogen (http://www2.niaid.nih.gov/Biodefense/bandc_priority.htm). NIAID is issuing this notice to the NIH Guide to highlight its interest in receiving grant applications focused on influenza research. Areas of high priority include, but are not limited to, the following:
Applications on influenza may be submitted under any of the following appropriate NIAID programs that are currently available.
Cooperative Research Partnerships for Influenza Product Development (U01)
Biodefense and Emerging Infectious Disease Research Opportunities (PA-04-119)
SBIR Advanced Technology – NIAID (SBIR-AT-NIAID) (PA-04-127)
Small Business Innovation Research Program Parent Announcement (see Small Business Funding Opportunities web page)
Small Business Technology Transfer Program Parent Announcement (see Small Business Funding Opportunities web page)
NIH Small Research Grant Program (R03) (PA-03-108)
NIAID Centers of Excellence for Influenza Research and Surveillance (NIH-NIAID-DMID-BAA-07-20)
Additional information can be obtained by contacting the program contact listed in the individual announcements above.
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
Office of Extramural
National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
Department of Health
and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.